Roche Launches Its First Global Accelerator in Shanghai to Nurture Leading Chinese Healthcare Innovators

Original Title: Roche Launches World's First Accelerator in Shanghai to Incubate and Support High-Quality Chinese Medical Innovation Enterprises

On May 18, Roche signed strategic cooperation agreements with GL Ventures and Zhangjiang Group, respectively, marking the official launch of the Roche China Accelerator at the Roche Campus in Zhangjiang Hi-Tech Park, Shanghai. As Roche's first self-established and operated accelerator globally, the facility represents an investment exceeding RMB 200 million and will offer tailored support programs for startups in innovative drugs, diagnostics, personalized medicine, and artificial intelligence. Resident startups will gain access to Roche's end-to-end localized resources spanning the entire value chain from early-stage R&D to late-stage commercialization, including scientific and technical guidance, business strategy advisory, and operational support. Additionally, they will have the opportunity to secure financial backing in the form of research grants.